Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation

NCT04338958 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
193
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Jena